(Q35978327)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

A C Ogilvie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

J W Baars

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

A J Eerenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

C E Hack

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

H M Pinedo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

L G Thijs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

English

0 references

publication date

1 March 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

596-598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

Reduction of toxicity of interleukin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroids

25 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968861

Proteolytic inactivation of plasma C1- inhibitor in sepsis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968861

Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968861

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968861

Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968861

C1-esterase inhibitor substitution in sepsis

24 September 2018

1 reference

12 December 2020

Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes

1 reference

12 December 2020

Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfa

1 reference

12 December 2020

The systemic complement activation caused by interleukin-2/lymphokine-activated killer-cell therapy of cancer causes minimal systemic neutrophil activation

1 reference

12 December 2020

A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

release_26ainsft2vgcriwetlytsndv6q

25 October 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/26ainsft2vgcriwetlytsndv6q

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8123494%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

PubMed publication ID

8123494

1 reference